These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 8235617)

  • 21. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.
    Coffin JM
    Science; 1995 Jan; 267(5197):483-9. PubMed ID: 7824947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The chemical therapy of HIV infections. Strategies, results, prospects].
    Eşanu V
    Rev Roum Virol; 1992; 43(3-4):221-66. PubMed ID: 1308434
    [No Abstract]   [Full Text] [Related]  

  • 23. The George M. Kober lecture. Basic immunology: the path to the delineation of the immunopathogenic mechanisms of HIV infection.
    Fauci AS
    Trans Assoc Am Physicians; 1988; 101():clx-clxxiii. PubMed ID: 2908369
    [No Abstract]   [Full Text] [Related]  

  • 24. T lymphocytes and their cytokines in human immunodeficiency virus (HIV) infection: implications for associated neoplasias.
    Jassoy C; Walker BD
    Crit Rev Oncog; 1995; 6(3-6):275-89. PubMed ID: 9012587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How does HIV cause AIDS?
    Weiss RA
    Science; 1993 May; 260(5112):1273-9. PubMed ID: 8493571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Present status and future prospects for HIV therapies.
    Johnston MI; Hoth DF
    Science; 1993 May; 260(5112):1286-93. PubMed ID: 7684163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy of AIDS patients--classical strategies and proposals for novel therapeutic approaches (a short review).
    Minárovits J; Berencsi G; Nász I; Földes I
    Acta Microbiol Hung; 1988; 35(4):361-70. PubMed ID: 3072823
    [No Abstract]   [Full Text] [Related]  

  • 28. AIDS pathogenesis: from models to viral dynamics in patients.
    Nowak MA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S1-5. PubMed ID: 8595501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AIDS vaccines. Immune Response Corp.--take two.
    Cohen J
    Science; 1994 Jun; 264(5164):1402. PubMed ID: 7910980
    [No Abstract]   [Full Text] [Related]  

  • 30. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89.6PD infection in rhesus macaques.
    Wallace M; Pyzalski R; Horejsh D; Brown C; Djavani M; Lu Y; Hanson JM; Mitchen JL; Perlman SB; Pauza CD
    Virology; 2000 Sep; 274(2):255-61. PubMed ID: 10964769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine regulation of HIV expression.
    Fauci AS
    Lymphokine Res; 1990; 9(4):527-31. PubMed ID: 2090879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of the acquired immune deficiency syndrome.
    Gupta S; Gottlieb MS
    J Clin Immunol; 1986 May; 6(3):183-93. PubMed ID: 2424929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive immunotherapy in treatment of advanced human immunodeficiency virus infection.
    Karpas A
    J Infect Dis; 1994 Sep; 170(3):742-4. PubMed ID: 8077741
    [No Abstract]   [Full Text] [Related]  

  • 34. Cellular activation and human immunodeficiency virus infection.
    Virelizier JL
    Curr Opin Immunol; 1989-1990 Feb; 2(3):409-13. PubMed ID: 2576770
    [No Abstract]   [Full Text] [Related]  

  • 35. Toward an understanding of the correlates of protective immunity to HIV infection.
    Haynes BF; Pantaleo G; Fauci AS
    Science; 1996 Jan; 271(5247):324-8. PubMed ID: 8553066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced rate of disease development after HIV-2 infection as compared to HIV-1.
    Marlink R; Kanki P; Thior I; Travers K; Eisen G; Siby T; Traore I; Hsieh CC; Dia MC; Gueye EH
    Science; 1994 Sep; 265(5178):1587-90. PubMed ID: 7915856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathogenicity of human immunodeficiency virus (HIV)].
    Kurimura K
    Uirusu; 1991 Dec; 41(2):77-84. PubMed ID: 1810087
    [No Abstract]   [Full Text] [Related]  

  • 38. Inducing viral immunity without a vaccine--possible use with human immunodeficiency virus.
    Stone OJ
    Med Hypotheses; 1993 Feb; 40(2):95-6. PubMed ID: 8455482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of phenotyping and replication capacity in anti-HIV therapeutics.
    Baliga CS; Sutton RE
    Curr Opin Mol Ther; 2004 Jun; 6(3):308-17. PubMed ID: 15264434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS).
    Roy S; Wainberg MA
    J Leukoc Biol; 1988 Jan; 43(1):91-7. PubMed ID: 3275735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.